Anti-hepatitis medicinal preparation

A pharmaceutical preparation and anti-hepatitis technology, applied in the direction of antiviral agents, drug combinations, medical preparations containing active ingredients, etc., can solve problems such as easy conversion to liver cirrhosis, achieve significant therapeutic effect, definite curative effect, and overcome toxic and side effects Effect

Inactive Publication Date: 2013-01-16
GUANGXI UNIV OF CHINESE MEDICINE
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There is no specific drug for its treatment at present, and it is easy to turn into liver cirrhosis and liver cancer if it is not cured for a long time.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach 1

[0016] Embodiment 1. The preparation of capsules is to extract aucubin (glucoside) or glucoside (glucoside) yuan from natural plants such as eucommia ulmoides, add an appropriate amount of pharmaceutically conventional adjuvant, mix well, and pack in hollow capsules. have to.

Embodiment approach 2

[0017] Embodiment 2. Male, 30 years old, diagnosed with acute hepatitis B. Take 12 capsules every day, and 15 days is a course of treatment. After taking medicine for five courses of treatment, check that the liver function is normal. After stopping the drug, the liver function and the five items of hepatitis B were checked once a month, and the two checks were all normal. There was no recurrence in the 1-year follow-up.

Embodiment approach 3

[0018] Embodiment 3: Among the 36 cases treated clinically with capsules, there were 24 males and 12 females; the oldest was 68 years old and the youngest was 17 years old; among them, 21 cases were 17-44 years old, and 15 cases were 45-68 years old; the shortest medical history before treatment was 13 18 cases of acute hepatitis B, 9 cases of chronic persistent hepatitis, 8 cases of chronic active hepatitis, 1 case of early liver cirrhosis, and 18 cases of hepatitis B virus carrier. The total effective rate is 80.00%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an anti-hepatitis medicinal preparation. The invention is characterized in that the medicinal preparation is prepared by taking aucubin (aucuboside) or aglycone (aglucone) as a raw material. The invention aims to provide the anti-hepatitis medicinal preparation. A preparation method for the anti-hepatitis medicinal preparation is characterized in that by taking the aucubin (aucuboside) or the aglycone (aglucone) as the raw material, pharmaceutically conventional auxiliary materials are added to prepare any dosage forms, such as injections, granules, tablets, capsules, pills, medicinal tea, powder, dripping pills, soft extracts, mixtures and syrups recorded in Chinese pharmacopoeia. The defect that toxic and side effects with different degrees are caused by pharmaceutically treating hepatitis at present is overcome by the anti-hepatitis medicinal preparation. The anti-hepatitis medicinal preparation has the following advantages: 1, the curative effect is exact, and the treatment effect is remarkable; 2, the raw material of the anti-hepatitis medicinal preparation can be extracted from plants, such as Eucommia ulmoides, thus, resources are rich and can be easily obtained; 3, the anti-hepatitis medicinal preparation has an effect of resisting the hepatitis, and is used for treating acute and chronic hepatitis B, viral hepatitis, chemical liver injury, fatty liver and cirrhosis.

Description

Technical field: [0001] The invention relates to an anti-hepatitis pharmaceutical preparation, specifically a pharmaceutical preparation prepared from aucubin (glucoside) or aglycone (glycoside). Background technique: [0002] Hepatitis B is a disease caused by infection of the body with the hepatitis B virus (HBV). There are two types of hepatitis B: acute and chronic. Acute hepatitis B can be cured in 90% of adults, while chronic hepatitis B has different manifestations, including chronic hepatitis B carriers, chronic active hepatitis B, and hepatitis B cirrhosis. Hepatitis B virus is a hepatotropic virus that mainly exists in liver cells and damages liver cells, causing inflammation, necrosis, and fibrosis of liver cells. Hepatitis B is a highly contagious common and frequently-occurring disease that seriously endangers human health. Relevant data prove that the incidence rate and hepatitis B virus carriers in my country rank first in the world. There is no specific dr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61K31/352A61P1/16A61P31/20
Inventor 谭建宁
Owner GUANGXI UNIV OF CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap